By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

By any economic measure, the Food and Drug Administration (FDA) is one of the most important regulatory bodies in the federal ...